Table of Content
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Drug Volume: Production and usage volumes of pharmaceuticals.
5.4 Healthcare Spending: Expenditure data by government, insurers, and out-of-pocket by patients.
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Business Model Benchmarking
6.3.1 Business Model specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and supply chain strategies
6.4.3 Expansion plans and new Business Model launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. U.S. Pharmacy Benefit Management Market Segmentation, by Business Model
7.1 Chapter Overview
7.2 Standalone PBM
7.2.1 Standalone PBM Market Trends Analysis (2020-2032)
7.2.2 Standalone PBM Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Health Insurance Providers
7.3.1 Health Insurance Providers Market Trends Analysis (2020-2032)
7.3.2 Health Insurance Providers Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Retail Pharmacy
7.4.1 Retail Pharmacy Market Trends Analysis (2020-2032)
7.4.2 Retail Pharmacy Market Size Estimates and Forecasts to 2032 (USD Billion)
8. U.S. Pharmacy Benefit Management Market Segmentation, by End-use
8.1 Chapter Overview
8.2 Commercial
8.2.1 Commercial Market Trends Analysis (2020-2032)
8.2.2 Commercial Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Federal
8.3.1 Federal Market Trends Analysis (2020-2032)
8.3.2 Federal Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Company Profiles
9.1 MedImpact
9.1.1 Company Overview
9.1.2 Financial
9.1.3 Business Models/ Services Offered
9.1.4 SWOT Analysis
9.2 Elixir Rx Solutions LLC
9.2.1 Company Overview
9.2.2 Financial
9.2.3 Business Models/ Services Offered
9.2.4 SWOT Analysis
9.3 CVS Health
9.3.1 Company Overview
9.3.2 Financial
9.3.3 Business Models/ Services Offered
9.3.4 SWOT Analysis
9.4 HUB International Limited
9.4.1 Company Overview
9.4.2 Financial
9.4.3 Business Models/ Services Offered
9.4.4 SWOT Analysis
9.5 Cigna
9.5.1 Company Overview
9.5.2 Financial
9.5.3 Business Models/ Services Offered
9.5.4 SWOT Analysis
9.6 Anthem
9.6.1 Company Overview
9.6.2 Financial
9.6.3 Business Models/ Services Offered
9.6.4 SWOT Analysis
9.7 Prime Therapeutics LLC
9.7.1 Company Overview
9.7.2 Financial
9.7.3 Business Models/ Services Offered
9.7.4 SWOT Analysis
9.8 Change Healthcare
9.8.1 Company Overview
9.8.2 Financial
9.8.3 Business Models/ Services Offered
9.8.4 SWOT Analysis
9.9 CVS Caremark
9.9.1 Company Overview
9.9.2 Financial
9.9.3 Business Models/ Services Offered
9.9.4 SWOT Analysis
9.10 Express Scripts
9.9.1 Company Overview
9.9.2 Financial
9.9.3 Business Models/ Services Offered
9.9.4 SWOT Analysis
10. Use Cases and Best Practices
11. Conclusion
